The CDC is now "in line with current science and supports a patient-centered approach," said Shannon Weber, M.S.W., which can mean "accessible safer-conception options for thousands of Americans living and loving with HIV."
Some heterosexual men living with HIV assume they have to forego fatherhood and mixed-status relationships. Providers can help dispel these misconceptions by having conversations about reproductive health with their patients.
Expert: Long-Awaited CDC HIV Report on Conception Options for Serodiscordant Couples Is Disappointing and Confusing
We're in the middle of a revolution in our efforts to fight HIV. However, you wouldn't know it from a new U.S. health department agency report that advises providers about conception when one partner is living with HIV.
Here are the latest updates to the HIV treatment guidelines for pregnant women, from the U.S. Department of Health and Human Services. Among the updates are "what to start" treatment changes and safety and toxicity information.
On June 17, 2016, the U.S. Food and Drug Administration approved updates to the Prezista (darunavir) labeling to include information on the use of darunavir in pregnant women.
New updates to the guidelines for preventing mother-to-child HIV transmission and for prevention and treatment of opportunistic infections in adults and adolescents.
After extensive review of published articles and conference reports on raltegravir use in pregnancy, researchers found that "raltegravir appears safe and effective in preventing mother-to-child transmission in late pregnancy."
Researchers found that regimens containing integrase inhibitors could reduce viral loads by tenfold (one log) in as short as one week in pregnant HIV-positive women.
Adolescent pregnant women had an increased risk of vertical transmission of HIV and poorer maternal and infant outcomes, compared to non-adolescent women, in a high HIV prevalence district in South Africa.
Two small studies presented at the 5th International Workshop on HIV & Women evaluated the pharmacokinetics of darunavir/ritonavir (DRV/r) and etravirine (ETV) respectively in pregnancy. In both studies drug exposure was altered -- lower for DRV and ...